Fabio Arturo Iannotti Selected Research

Fabio Arturo Iannotti Research Topics

Disease

5	Schizophrenia (Dementia Praecox) 10/2022 - 01/2019
5	Obesity 12/2021 - 11/2013
5	Epilepsy (Aura) 05/2021 - 01/2010
4	Cognitive Dysfunction 10/2022 - 01/2019
3	Inflammation (Inflammations) 02/2021 - 04/2016
3	Neuralgia (Stump Neuralgia) 02/2021 - 12/2019
3	Hyperalgesia 02/2021 - 01/2018
2	Substance-Related Disorders (Drug Abuse) 05/2021 - 01/2021
2	Neurobehavioral Manifestations 01/2021 - 01/2020
2	Brain Concussion (Cerebral Concussion) 01/2020 - 01/2020
1	Chronic Disease (Chronic Diseases) 02/2021
1	Cytokine Release Syndrome 02/2021
1	Keratitis 02/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Peripheral Nerve Injuries 01/2021
1	Overweight 01/2021
1	Chronic Pain 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 09/2020
1	Anhedonia 09/2020
1	Leukemia 12/2019
1	Pain (Aches) 09/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Vascular Remodeling 04/2016
1	Neoplasms (Cancer) 04/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Anorexia 11/2013
1	Body Weight (Weight, Body) 11/2013
1	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 01/2011

Drug/Important Bio-Agent (IBA)

8	EndocannabinoidsIBA 10/2022 - 01/2016
6	CannabidiolIBA 05/2021 - 01/2019
4	LipidsIBA 01/2021 - 01/2016
3	Methylazoxymethanol AcetateIBA 10/2022 - 01/2019
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2020
3	CannabinoidsIBA 01/2021 - 11/2013
2	AM 251 (AM251)IBA 10/2022 - 01/2019
2	Antimitotic AgentsIBA 10/2022 - 01/2019
2	OrexinsIBA 10/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
2	2-pentadecyl-2-oxazolineIBA 01/2021 - 01/2020
2	Potassium Channels (Potassium Channel)IBA 09/2019 - 01/2010
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2011 - 01/2010
1	LeptinIBA 12/2021
1	Rosiglitazone (Avandia)FDA Link 12/2021
1	noladin etherIBA 12/2021
1	Glucosamine (Dona)IBA 02/2021
1	GlycolipidsIBA 02/2021
1	NF-kappa B (NF-kB)IBA 02/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2021
1	CytokinesIBA 02/2021
1	Lipid AIBA 02/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021
1	MonosaccharidesIBA 02/2021
1	Prostaglandins AIBA 02/2021
1	Formaldehyde (Formol)FDA Link 02/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Orexin ReceptorsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 09/2020
1	anandamide (arachidonylethanolamide)IBA 09/2020
1	Alanine (L-Alanine)FDA Link 09/2020
1	AmidesIBA 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2020
1	Naloxone (Narcan)FDA LinkGeneric 09/2020
1	SaccharinIBA 09/2020
1	N-oleoylglycineIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Dopamine D3 ReceptorsIBA 01/2020
1	Substance PIBA 12/2019
1	palmidrolIBA 12/2019
1	Capsaicin (Zostrix)FDA Link 09/2019
1	BradykininIBA 09/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2019
1	DystrophinIBA 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Polychlorinated Biphenyls (PCBs)IBA 01/2019
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019
1	cannabidivarinIBA 01/2019
1	Inflammation MediatorsIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Transient Receptor Potential ChannelsIBA 11/2014
1	RimonabantIBA 11/2013
1	Pharmaceutical PreparationsIBA 01/2010
1	ezogabine (retigabine)IBA 01/2010

Therapy/Procedure

2	Therapeutics 09/2019 - 01/2010
1	Fecal Microbiota Transplantation 12/2021
1	Aftercare (After-Treatment) 01/2019